bringing you the latest and original global medtech industry dynamics
Over 400 companies applied for the Asia Pacific program this year, and after a rigorous selection process, 60 companies were invited to pitch, 24 of which were named to the 2023 cohort.
Read More
the Diagnostic Facility will produce a wide range of diagnostic reagents for cardiac, thyroid, sex hormone, and oncology, as well as calibrators, diluents and quality control products for immuno-diagnostics, with an expected annual capacity of 600 million tests
Read More
DECs are to be located at current Olympus R&D sites in London, Hamburg, Boston and Tokyo, with the possibility of expanding to Silicon Valley and Tel Aviv at a later stage.
Read More
which will be used for clinical trials of its digestive endoscopic surgical robot products and research and development of new products
Read More
Acquisition will expand its ability to serve more people living with diabetes around the world within one seamless Medtronic ecosystem of support
Read More
The VisAR system is a comprehensive solution that includes pre-surgical planning, virtual annotations, segmentation, as well as two-way image connectivity
Read More
Body Vision Medical signs exclusive distribution agreements in Czech Republic, India, Malaysia and Thailand.
Read More
Weekly review of Global MedTech industry, presented by G-MedTech
Read More
ICP DAS – BMP offers visitors ideal medical manufacturing materials, including three series of Alithane™ (ALP series), Durathane™ (ALC series), and Arothane™ (ARP series)
Read More
Marks Important Milestone in Commercialization of Blood Screening Tool that is Intended to be used Alongside Current Breast Cancer Screening Methods
Read More
English (UK) 
简体中文 
Deutsch 
Français 
Español 
Português 
Italiano 
Nederlands